Page 43 - CIBEROBN-2015-eng

Most relevant scientific articles
Research Groups
TOLEDO E., SALAS-SALVADO J., DONAT-VARGAS C., BUIL-CO- SIALES P., ESTRUCH R., ROS E. ET AL. Mediterranean diet and invasive breast cancer risk among women at high car- diovascular risk in the predimed trial a randomized clinical trial. JAMA Internal Medicine. 2015;175(11):1752-1760.
GUASCH-FERRE M., BABIO N., MARTíNEZ-GONZáLEZ M.A., CO- RELLA D., ROS E., MARTIN-PELAEZ S. et al. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease. Ame-
MERINO J., GUASCH-FERRE M., MARTíNEZ-GONZáLEZ M.A., CORELLA D., ESTRUCH R., FITO M. ET AL. Is complying with the recommendations of sodium intake beneficial for health in individuals at high cardiovascular risk? Findings from the PREDIMED study. American Journal of Clínical Nutrition. 2015;101(3):440-448.
MEDINA-REMON A., TRESSERRA-RIMBAU A., PONS A., TUR J.A., MARTORELL M., ROS E. ET AL. Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in
rican Journal of Clínical Nutrition. 2015;102(6):1563-1573.
VALLS-PEDRET C., SALA-VILA A., SERRA-MIR M., CORELLA D., DE LA TORRE R., MARTíNEZ-GONZáLEZ M.A. ET AL. Mediterranean diet and age-related cognitive decline: A randomized clini- cal trial. JAMA Internal Medicine. 2015;175(7):1094-1103.
Highlights
Our group has published over 150 research papers in journals such as New England Journal of Medici- ne, Annals of Internal Medicine, JAMA, Archives of Medicine, Annals of Neurology and Archives of Neu- rology, American Journal of Clinical Nutrition and the Journal of Nutrition. Currently, we participate in the PREDIMED Plus study; it would assess the effect on adiposity, cardiovascular risk factors and quality of life of an intensive weight loss intervention based on a low calorie Mediterranean diet, physical activity and behavioral therapy, the effects of the Mediterra-
a high cardiovascular risk cohort. The PREDIMED rando- mized trial. Nutrition, Metabolism and Cardiovascular Di- seases. 2015;25(1):60-67.
nean diet on the primary prevention of cardiovascu- lar disease, now framed in the CIBERobn. In parallel, we are carrying out a study to reduce body weight with a natural plant extracts, participate in the In- terciber INFLAMES Project and designing a new randomized parallel group controlled intervention trial on the protective effects of moderate alcohol consumption on cardiovascular disease (MACH 14 trial) that will included 20 centers from USA, Europe, Africa, Australia and South America.
Institution: Hospital Clínic de Barcelona · Contact: C/. Villarroel, 170. 08036 Barcelona · Tel.: 93 227 54 00 · E.mail: [email protected] · Website: http://www.hospitalclinic.org/es
CIBEROBN I Annual report 2015 I 43